These data are relevant in light of the fact that GC7 is considered a potent and selective inhibitor of DHS and is a potential candidate drug for cancer, diabetes and HIV therapy.
Introduction
Spermidine is a natural polyamine ubiquitously highly present in all living organisms; it has been implicated in many pathophysiological processes including cellular proliferation, transformation, differentiation, apoptosis, ageing and tumorigenesis (Gerner and Meyskens 2004; Pegg 2009; Igarashi and Kashiwagi 2010; Mandal et al. 2013) . The exogenous administration of spermidine promotes longevity in many model organisms including yeast, nematodes and flies, and significantly reduces age-related oxidative protein damage in mice (Eisenberg et al. 2009; Madeo et al. 2010; Morselli et al. 2011; Tirupathi et al. 2011) . It has been postulated that the anti-age activity of spermidine could be related to this molecule's ability to modulate the autophagic process (Eisenberg et al. 2009 ). Of note, spermidine plays a pivotal role in the post-translational modification of the eukaryotic initiation factor 5A (eIF5A), consisting in protein hypusination (Huang et al. 2007 ). eIF5A is a small (17 kDa) acidic protein carrying a unique polyamine-derived amino acid, hypusine [Nε-(4-amino-2-hydroxybutyl)lysine] (Caraglia et al. 2013; Shiba et al. 1971; Cooper et al. 1982) .
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Hypusine is synthesized from the polyamine spermidine in two sequential enzymatic steps: in the first step deoxyhypusine synthase (DHS) catalyzes the transfer of the aminobutyl moiety from spermidine to a specific lysine residue (Lys50 in human eIF5A) to form the deoxyhypusine intermediate, [Nε-(4-aminobutyl)-lysine] residue; the intermediate is subsequently hydroxylated by deoxyhypusine hydroxylase (DOHH) to produce active hypusinated eIF5A (Park 2006) (Fig. 1) . Two isoforms of eIF5A sharing 84 % homology exist in humans although showing distinct biological functions (Caraglia et al. 2013) . eIF5A-1 is ubiquitously expressed and its level is particularly high in proliferating cells; by contrast, eIF5A-2 has a more restricted expression (Jenkins et al. 2001; Guan et al. 2004 ). There are a lot of evidences to indicate that eIF5A is a key protein in the pathogenicity of different diseases, such as diabetes, several human cancers, malaria and HIV-1 infection (Kaiser 2012) .
Although the physiological role of eIF5A-1 has not yet been fully elucidated, it has been found to function: (a) as a translation elongation factor during protein synthesis (Saini et al. 2009 ), (b) as a cytoplasmic shuttling protein regulating mRNA transport (Liu et al. 1997; Maier et al. 2010) and (c) as a cellular cofactor of HIV-1 REV (Benne and Hershey 1978) . It has also been implicated in the regulation of mRNA turnover (Zuk and Jacobson 1998) , cell proliferation (Park et al. 1993 , differentiation (Schnier et al. 1991; Park et al. 2010) , inflammation, (Moore et al. 2008 ) and apoptosis (Taylor et al. 2013) . Interestingly, the pro-apoptotic function of eIF5A-1 appears to be the only eIF5A activity which is independent from hypusine modification (Taylor et al. 2007 (Taylor et al. , 2012 Sun et al. 2010) . Growing evidence indicates that apoptosis induction is often associated with decreased autophagy, underlying the existence of an interplay between these two important cellular events (Fimia and Piacentini 2010) .
Autophagy is an intracellular degradation system which delivers cytoplasmic constituents to the lysosome (Xie and Klionsky 2007) . This is a highly conserved process in eukaryotes and has two main physiological functions: it removes unwanted/aged/damaged constituents and recycles cytoplasmic materials to maintain macromolecular synthesis and energy homeostasis during stressful conditions including nutrient deprivation, hypoxia and low energy status.
Although Patel et al. (2009) have hypothesized that the Drosophila deoxyhypusine hydroxylase homologue Nero and its target eIF5A are involved in autophagy regulation, no direct evidence shows eIF5A's involvement in the autophagic process, at least until now. On the other end, what has been recently demonstrated is spermidine's ability to stimulate autophagy in yeast, nematodes and flies, increasing the overall lifespan (Morselli et al. 2011) , albeit the molecular mechanism is still unclear.
Therefore, since spermidine is directly required for eIF5A modification by hypusination, we asked whether mature eIF5A may represent the link between spermidine and autophagy. To test this hypothesis, we inhibited the conversion of native eIF5A by both pharmacological and genetic approaches and evaluated the impact on autophagy. Here we show that GC7 has an off-target effect, since its administration results in cell basal autophagy induction, independently of eIF5A activity.
Materials and methods

Materials
Mouse Anti-eIF-5a (BD 611976; dilution 1:10,000) was from BD Biosciences; rabbit anti-DHS (sc-67161; dilution 1:1,000) and mouse anti-Gapdh (sc-47724; dilution 
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1:1,000) were from Santa Cruz Biotechnology; rabbit anti-LC3 (NB100-2331; dilution 1:500) and Rat anti-FLAG (dilution 1:500) were from Novus Biologicals.
The anti-mouse or anti-rabbit secondary antibodies HRP-conjugated (dilution 1:5,000) and the ECL detection system (Immun-StarTM WesternTM Kit) were from BioRad. Earle's balanced salt solution (EBSS), Bafilomycin A1, chloroquine, E64D and Pepstatin A were obtained from Sigma. N1-Guanyl-1,7-diaminoheptane (GC7) was from Biosearch Technologies; D-MEM and FBS were from Invitrogen Life Technologies.
Cell culture and treatments
Human fibrosarcoma 2fTGH cells (2F) were cultured in Dulbecco's modified Eagle's medium (D-MEM) supplemented with 10 % foetal bovine serum, 2 mM l-glutamine, 100 mg/ ml streptomycin and 100 units/ml penicillin. Cells were grown in a humidified atmosphere containing 5 % CO 2 at 37 °C.
2 × 10 5 cells were treated with 200 µM GC7 (dissolved in 10 mM of acetic acid), 10 nM Bafilomycin A1 (BafA), 10 µg/ml of both E64d and Pepstatin A, as indicated. All compounds were dissolved in DMSO except GC7 that was dissolved in 10 mM acetic acid.
Western blotting
Cells were rinsed in ice-cold phosphate-buffered saline (PBS) and collected in lysis buffer (20 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 % Triton X-100) plus protease and phosphatase inhibitors (protease inhibitor cocktail, 1 mM sodium fluoride, 1 mM sodium orthovanadate, Sigma). Samples were centrifuged 15 min at 9,000×g and, total protein concentration was evaluated by the DC protein Kit (Bio-Rad). Proteins were resolved by a 12 % SDS-PAGE and transferred onto a nitrocellulose membrane. Membranes incubated 1 h with 5 % nonfat dry milk in T-PBS containing 0.05 % Tween 20 (1 h) and then incubated overnight with indicated antibodies, at 4 °C. After three washes with T-PBS, membranes were incubated 1 h with HRP-conjugated secondary antibody, at rt. Membranes were rinsed three times with T-PBS, and the signal was detected by enhanced ECL Immunostar detection system from BioRad.
Retroviral expression of GFP-p62 and mRFP-GFP-LC3
Fifteen microgram of retroviral vectors (GFP-p62 or RFP-GFP-LC3) was co-transfected with 5 μg of an expression plasmid for the vesicular stomatitis virus G protein into 293 gp/bsr cells using the calcium phosphate method. After 48 h, the supernatant containing the retroviral particles was recovered and supplemented with polybrene (4 mg/mL). 2F cells were infected by incubation with retroviral-containing supernatant for 6-8 h, as previously described (Pagliarini et al. 2012 ).
Autophagy analysis
For confocal microscopy analysis, 2 × 10 5 cells were grown on glass cover slips, fixed using 4 % paraformaldehyde, and fluorescence analyzed by a Leica TCS SPII laser-scanning confocal microscope, as previously reported (Hill et al. 2009 ).
p62-GFP flow cytometric analysis was performed by monitoring the green-fluorescence intensity of p62 protein.
Briefly, 2fp62GFP cells were fixed by 4 % paraformaldehyde, 20,000 events were acquired by a FACScan cytometer (Becton-Dickinson) and data analyzed using CellQuest software (Pagliarini et al. 2012 ).
RNA interference
RNAi was performed using the following oligonucleotides from Ambion:
Oligos a-1 or b-1 were eIF5A Silencer Selected Predesigned siRNA # 4392420 or Custom Selected siRNA #4390827 for eIF5A-1; siRNA #4390824 for DHS and #12935-300 as a negative control (siCtrl).
5 × 10 5 cells/well were transfected with 100 pmol siRNA in a six-well plates using lipofectamine RNAimax (Invitrogen), as indicated by the supplier. Transfection was blocked after 24 h and cells treated as indicated.
qRT-PCR RNA was extracted using Trizol reagent (Invitrogen) as indicated by the supplier. cDNA synthesis was generated using a reverse-transcription kit (Promega, Madison, WI, USA) according to the manufacturer's recommendations. Quantitative PCRs were performed with the Rotor-Gene 6000 (Corbett Research Ltd) thermocycler. Primer sets for all amplicons were designed using the Primer-Express 1.0 software system (Roche):
L34 forward: 5′-GTCCCGAACCCCTGGTAATAGA-3′ L34 reverse: 5′-GGCCCTGCTGACATGTTTCTT-3′ DHS forward: 5′-GTGTAAAGTGGACGCCTTCTA-3′; DHS reverse: 5′-ACACAGGGATGTGGTTCTTC-3′; L34 mRNA level was used as an internal control and results were expressed as previously described (Pagliarini et al. 2012 ).
K50A eIF5A mutant p3XFLAG-CMV-10.1 encoding for human eIF5A-1 was kindly provided by Myung Hee Park National Institute of Dental and Craniofacial Research "NIDCR" Bethesda, MD (Clement et al. 2006 ). The mutant K50A was obtained in our lab using Quick Change Site-Directed Mutagenesis Kit (Stratagene). The primers used for mutate of the plasmid p3XFLAG-eIF5A-1 in the Lysine50 (p3XFLAG-K50A) were: eIF5A K50A 5′-CTTCGAAGACTGGCGCGCACGGCC ACGCCA-3′ eIF5A K50A antisense 5′-TGGCGTGGCCGTGCGCG CCAGTCTTCGAAG-3′ p3XFLAG-eIF5A-1 was used as mutagenesis template. PCR amplification products were treated with restriction enzyme DpnI (Fermentas). An aliquot of 5 µl above PCR product was transformed into DH5a competent cells and inoculated on Luria-Beltrani (LB) plate containing 100 µg/ml ampicillin. A total of ten colonies were selected and their plasmids were isolated by mini-prep. The positive mutants were selected by DNA sequencing.
The wt and the mutant K50A of eIF5A were transiently transfected using lipofectamine LTX as indicated by the supplier.
Statistical analysis
All experiments were performed in replicate and repeated three times. Results were expressed as mean ± SD of three experiments. Data were analyzed by the t Student test and differences were considered significant when p < 0.05.
Results
The inhibitor of eIF5A activity, GC7, increases basal autophagy To elucidate the role of eIF5A in the autophagic pathway we used the fibrosarcoma cell line 2fTGH (2F) as a model eIF5A is not involved in autophagy 1 3
and N1-guanyl-1,7-diamineoheptane (GC7), a spermidine analogue that competitively and reversibly inhibits deoxyhypusine synthase (DHS; Lee and Folk 1998; Park et al. 1993; Shi et al. 1996) , to inhibit eIF5A hypusination. GC7 is commonly used to block the first step of hypusination of eIF5A, resulting in the accumulation of the native protein (Landau et al. 2010) . Characteristic features of early and late stages of autophagy were used to measure autophagy in 2F cells, such as the conversion of unconjugated LC3 (LC3-I) to the lipidated form (LC3-II), and the degradation of p62. First, we analyzed the effect of the inhibition of eIF5A hypusination on basal or induced autophagy. To this end, autophagy was stimulated using EBSS medium (starvation, stv) in 2F cells stably expressing a p62-GFP recombinant protein (2F-p62GFP cell line); cells were treated or untreated 18 h with 200 µM GC7 in the presence or absence of 10 nM Bafilomycin A1 (BafA1), and autophagy was evaluated by measuring the degradation of p62-GFP protein, by flow cytometry. As reported in Fig. 2a , we observed that the inhibition of eIF5A hypusination leads to a drastic degradation of p62 in cells treated with GC7 alone. This potent GC7 pro-autophagic effect was also able to potentiate the starvation-induced p62 degradation. The positive effect of GC7 on the autophagic flux was also confirmed by the accumulation of p62 upon treatment with BafA1. To confirm these findings, 2F cells were treated for 24, 48 or 72 h with 200 µM GC7 in the presence or absence of 10 µg/ml of both E64D and PepstatinA (PepA), two inhibitors of autolysosome degradation activity, and autophagy induction was evaluated by monitoring the LC3 conversion by Western blotting analysis. As reported in Fig. 2b , GC7 treatment increased basal autophagy in a time-dependent manner as evidenced by the enhanced accumulation of LC3-II in the presence of E64D/PepA. Similar results were obtained in 2Fp62GFP cells in the same experimental conditions, by measuring the degradation of p62-GFP, by flow cytometric analysis (Fig. 2c) . To further support these data the p62-GFP degradation was also evaluated by confocal analysis in 2Fp62GFP cells treated or untreated with GC7. This analysis confirmed that the GC7 administration per (Fig. 2d, bottom panels) . Finally, to confirm that the GC7 effect resides in autophagy induction and not in the inhibition of autophagic flux, we used a GFP-RFP-tagged LC3 recombinant protein (Hill et al. 2009 ). To this end, 2F cells stably expressing GFP-RFP-LC3 were treated with GC7 or vehicle alone (Acetic Acid; 24 h) and autophagy induction was evaluated by confocal analysis. EBSS medium (stv) was used as a positive control. Data reported in Fig. 3 clearly show a dramatic cytosolic accumulation of red-puncta LC3 dots (representing autophagolysosome, mature structures), compared to yellow-puncta ones (representing autophagosome, immature structures), in respect to both vehicle-alone or EBSS-treated cells, indicating a GC7-dependent enhanced complete autophagy induction, but not inhibition of autophagic flux.
eIF5A has no functional role in basal cell autophagy To validate by a genetic approach the consistency of our results indicating that eIF5A has a functional role in autophagy, we transiently inhibited the expression of eIF5A-1 (the isoform expressed in 2F cells), using specific siRNA oligos (sieIF5A; Fig. 4a ), and cell basal autophagy was evaluated by measuring the conversion of LC3, by Western blotting analysis, in the presence or absence of BafA1 (Fig. 4b) .
Although the expression of eIF5A-1 was almost completely inhibited by siRNA oligos (Fig. 4a) , the LC3 conversion was only marginally affected, compared to control (siCtrl; Fig. 4b) .
Similar results were obtained in 2Fp62GFP cells in the same experimental conditions, by monitoring the degradation of p62-GFP in cells in which the expression of eIF5A-1 was inhibited by siRNA oligos, compared to control (siCtrl; Fig. 4c ). These findings suggest that the potent pro-autophagic activity displayed by GC7 was due to an off-target effect not related to the post-translational modification of eIF5A. To support this hypothesis, we decided to verify that also the eIF5A immature form (with no hypusine modification) was also not involved in modulating the autophagic process. To this end, we inhibited the modification of the native eIF5A protein by down-regulating the expression of DHS by the transient transfection of specific siRNA oligo into 2Fp62GFP cells. The inhibition was evaluated by monitoring both eIF5A protein and RNA levels (Fig. 5a ). In these cells we analyzed the basal autophagy in the presence or absence of BafA1, by monitoring both the LC3 conversion by Western blotting analysis (Fig. 5b) and p62 degradation by flow cytometry (Fig 5c) . The inhibition of DHS resulted in not statistically significant effects on basal autophagy as evidenced by both LC3-II accumulation and p62 degradation (Fig. 5b, c) .
Finally, to confirm that the accumulation of immature eIF5A resulting from inhibition of protein hypusination is not involved in autophagy induction/execution, we ectopically expressed both wild type and K50A mutant eIF5A in 2F cells by transient transfection. K50A mutant codes for an eIF5A protein in which the hypusination site (Lys50) has been abrogated (replaced with an Ala). As shown in Fig. 5d , the over-expression of both the wt and K50A eIF5A did not affect the basal autophagy of 2F cells, thus confirming the off-target effect of GC7 in the induction of autophagy.
Discussion
Spermidine plays an important role in ageing during which there is a decline of its levels in different mammalian organs (Scalabrino and Ferioli 1984) . The exogenous administration of spermidine promotes longevity in many model organisms including yeast, nematodes and flies, and significantly reduces age-related oxidative protein damage in mice (Eisenberg et al. 2009; Madeo et al. 2010; Morselli et al. 2011; Tirupathi et al. 2011 ). This increase in longevity is linked to changes in the acetylation of nuclear histones and to a transcriptional increase of different autophagy-related genes (Eisenberg et al. 2009 ). Furthermore, more recent studies have shown that spermidine induces autophagy through AMPK-dependent pathway which is well known to play an anti-ageing role (Morselli et al. 2011) . Spermidine plays a pivotal role in the post-translational modification of the eukaryotic initiation factor 5A (eIF5A) since it is the essential substrate for the protein hypusination (Huang et al. 2007 ). Under physiological conditions eIF5A is constitutively hypusinated, but its activity and subcellular localization can be conditioned by reversible acetylation (Lee et al. 2009; Ishfaq et al. 2012) . PCAF is the major cellular acetyltransferase of eIF5A, and HDAC6 and SIRT2 are its major deacetylases (Ishfaq et al. 2012) . Inhibition of the deacetylases or impaired hypusination increased acetylation of eIF5A, leading to its nuclear accumulation (Ishfaq et al. 2012) . Considering that the mechanism by which spermidine induces autophagy is not yet well elucidated, we asked whether hypusinated eIF5A can be the link in that process.
In this study, we analyzed the influence of eIF5A in the process of autophagy induced by starvation using several approaches: first, we blocked the conversion of native eIF5A into mature hypusinated protein by GC7 (N1-guanyl-1,7-diamineoheptane), or we used siRNA interference for knocking down the expression of native eIF5A and DHS or we over-expressed the native eIF5A or the mutated one in the hypusination site. Surprisingly, our results revealed not only that the GC7 alone can deregulate the basal autophagy, but also that this action is independent of eIF5A activity. GC7 is usually used to block the first step of hypusination of eIF5A which leads to the accumulation of the native protein (Landau et al. 2010) . Interestingly, the treatment with GC7 displays an anticancer effect in various tumours such as neuroblastoma, erythroleukaemia and melanoma (Shi et al. 1996; Chen et al. 1996; Lee et al. 2002; Jasiulionis et al. 2007 ). Lee et al. (2009) demonstrated that GC7 inhibits growth and differentiation in oral cancer and immortalized keratinocytes by inducing apoptosis through the mitochondrial and the AMPK pathways (Lee et al. 2009 ). The results reported in this study are the first evidence that GC7 induces autophagy in 2fTGH cell line.
These findings are interesting considering the complex role of autophagy in cancer initiation and progression. We expected to find a block in autophagy induction in the presence of the eIF5A-hypusination inhibitor GC7; surprisingly, by contrast, we revealed an off-target effect of the drug. In fact, the ablation of both the eIF5A itself or the enzyme mediating its hypusination, DHS, resulted in no appreciable change in the autophagic flux, thus confirming that the marked pro-autophagic effect of GC7 is not mediated by the hypusine pathway. In line with this conclusion, we also demonstrate that the over-expression of both wild type or K50A mutant eIF5A, in which the hypusination site (Lys50) has been replaced by an alanine, did not affect the basal autophagy in 2F cells confirming that the immature form of eIF5A (with no hypusine modification) is unrelated to the autophagic process.
In contrast to our initial hypothesis, collectively these data suggest that mature eIF5A (hypusinated form) is not involved in the autophagic pathway and that the inhibitor of deoxyhypusine synthase, GC7, has an off-target effect resulting in autophagy induction. Future studies should clarify by which mechanism GC7 is able to promote autophagy. In keeping with this assumption it is interesting to note that hypusine of the eIF-5A chain functions as an acyl acceptor substrate for transglutaminases (Beninati et al. 1995) . Considering the structural similarity between hypusine molecule and GC7, it would be interesting to study whether this polyamine analogue can act as a substrate of Type 2 transglutaminase transamidating activity which has been shown to play an important role in the recruitment of ubiquitinated proteins into the autophagosomes (D'Eletto et al. 2009 ). The GC7 off-target effect we demonstrated in this study is particularly relevant considering that this drug has been proposed as an important candidate for the therapy of cancer, diabetes and HIV infection. Indeed, eIF5A plays an important role in protein translation since disruption of the hypusination process by GC7 has been shown to inhibit the growth of many cancer cell types as well as endothelial cells (Lee et al. 2009 (Lee et al. , 2010 Caraglia et al. 2003) . For example, in hepatocellular carcinoma, over-expression of eIF5A2 was reported to be associated with tumour features that indicate poor prognosis, such as the presence of tumour metastasis and venous infiltration (Lee et al. 2010) . Furthermore, the clinical drugs ciclopirox and deferiprone, by inhibiting eIF5A hypusination, impair the transcription of the HIV-1 promoters and decrease HIV-1 gene expression (Hoque et al. 2009 ). Based on the considerable therapeutic interest in eIF5A as a selective target for drug development through inhibition of hypusination, the GC7 off-target effect described in this study acquires particular relevance and should be taken into full consideration for the use of GC7 in clinical trials.
